Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences. (Q51975366)

19 April 2018

title

Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences. (English)

1 reference

19 April 2018

author name string

van Grotel M

1

1 reference

19 April 2018

Meijerink JP

2

1 reference

19 April 2018

van Wering ER

3

1 reference

19 April 2018

Langerak AW

4

1 reference

19 April 2018

Beverloo HB

5

1 reference

19 April 2018

Buijs-Gladdines JG

6

1 reference

19 April 2018

Burger NB

7

1 reference

19 April 2018

Passier M

8

1 reference

19 April 2018

van Lieshout EM

9

1 reference

19 April 2018

Kamps WA

10

1 reference

19 April 2018

Veerman AJ

11

1 reference

19 April 2018

van Noesel MM

12

1 reference

19 April 2018

Pieters R

13

1 reference

19 April 2018

publication date

11 October 2007

1 reference

19 April 2018

published in

Leukemia

1 reference

19 April 2018

volume

22

1 reference

19 April 2018

issue

1

1 reference

19 April 2018

page(s)

124-131

1 reference

19 April 2018

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404957

exact match

0 references

cites work

A novel method to compensate for different amplification efficiencies between patient DNA samples in quantitative real-time PCR.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

Acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

Molecular genetics of childhood leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

Molecular cytogenetic study of 126 unselected T-ALL cases reveals high incidence of TCRbeta locus rearrangements and putative new T-cell oncogenes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

Gene expression profiling in T-cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

Significance of HOX11L2/TLX3 expression in children with T-cell acute lymphoblastic leukemia treated on Children's Cancer Group protocols.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

High incidence of Hox11L2 expression in children with T-ALL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

Expression of HOX11 in childhood T-lineage acute lymphoblastic leukaemia can occur in the absence of cytogenetic aberration at 10q24: a study from the Children's Cancer Group (CCG)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

Differentiation-linked leukemogenesis in lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: experience of the BFM study 86

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

Impact of TCR status and genotype on outcome in adult T-cell acute lymphoblastic leukemia: a LALA-94 study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

A classification based on T cell selection-related phenotypes identifies a subgroup of childhood T-ALL with favorable outcome in the COALL studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: results of DCLSG protocol ALL-8 (1991-1996).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

Translocation of BCR to chromosome 9: a new cytogenetic variant detected by FISH in two Ph-negative, BCR-positive patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

Split-signal FISH for detection of chromosome aberrations in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

Regenerating normal B-cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

Biallelic transcriptional activation of oncogenic transcription factors in T-cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

The oncogenic T cell LIM-protein Lmo2 forms part of a DNA-binding complex specifically in immature T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404957

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2404957

1 reference

19 April 2018

Dimensions Publication ID

0 references

1 reference

19 April 2018